A Revealing Exchange
Written by Jeff Green
In a Dan Wilson (Debunk the Funk) discussion with Christine Massey, Dan asked Christine how proteins are made by cells. Her response was, “I don’t know and I really don’t care.” —Christine Massey
The arguments made by Massey in the comments further below primarily revolve around sequencing and the assertion that the initial SARS-CoV-2 paper lacked protein analysis. However, it is important to note that the focus of the first paper was not on protein analysis. It should be acknowledged that a second paper, which served as a continuation of the initial one, did include protein analysis.
Note: Based on the evidence I have reviewed, it is my perspective that SARS-CoV-2 is part of a lineage of coronaviruses that have been observed in the past. I consider these viruses to be what I refer to as "proxy” or “reference” viruses, similar to other so-called dominant strains like Alpha, Delta, and Omicron. The genome of SARS-CoV-2 shares approximately 98% similarity with CoV-1 from 2003. A viral sample was initially obtained from a patient and subsequently sent to different laboratories for further analysis. In this sense, the virus is real and is not merely fictitious.
Scientific literature supports the fact that each time a patient sample is obtained, the virus has undergone changes compared to the previously observed strain. This variation occurs with every observed virus, as each virus does not possess identical RNA. Consequently, individuals who develop viral illnesses will exhibit minute variations in the virus sequence if observed, primarily due to RNA variances influenced by unique cellular characteristics.